2008
Modeling the Potential Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid Population
Bae SJ, Paltiel AD, Fuhlbrigge AL, Weiss ST, Kuntz KM. Modeling the Potential Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid Population. Value In Health 2008, 11: 110-118. PMID: 18237365, PMCID: PMC3476042, DOI: 10.1111/j.1524-4733.2007.00219.x.Peer-Reviewed Original ResearchMeSH KeywordsAdrenal Cortex HormonesAdultAge FactorsAnti-Asthmatic AgentsAsthmaCost SharingDrug PrescriptionsHealth Services AccessibilityHumansInsurance, Pharmaceutical ServicesMassachusettsMedicaidModels, EconometricNebulizers and VaporizersOutcome Assessment, Health CareState Health PlansTreatment RefusalUnited StatesConceptsFrequent acute exacerbationsAcute exacerbationCopayment increaseHealth outcomesPrescription drug copaymentsLikely health outcomesDrug nonadherenceCorticosteroid useAdult asthmaticsAcute eventDrug utilizationMedicaid populationDrug copaymentsMedicaid beneficiariesPrescription drugsCopaymentsReimbursement ratesFinancial burdenExacerbationTarget populationFirst yearNet savingsOutcomesPharmacyCommonwealth of Massachusetts
2006
Forced Expiratory Volume in 1 Second Percentage Improves the Classification of Severity Among Children With Asthma
Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. Forced Expiratory Volume in 1 Second Percentage Improves the Classification of Severity Among Children With Asthma. Pediatrics 2006, 118: e347-e355. PMID: 16864642, DOI: 10.1542/peds.2005-2962.Peer-Reviewed Original ResearchMeSH KeywordsAlbuterolAnti-Asthmatic AgentsAsthmaBronchial Provocation TestsBronchodilator AgentsBudesonideChildChild, PreschoolCohort StudiesDouble-Blind MethodEmergency Service, HospitalEthnicityFemaleFollow-Up StudiesForced Expiratory VolumeHospitalizationHumansMaleMethacholine ChlorideModels, TheoreticalMulticenter Studies as TopicNedocromilRandomized Controlled Trials as TopicRiskSeverity of Illness IndexSpirometryTreatment OutcomeConceptsSerious asthma exacerbationsImportant clinical outcomesHealth care utilizationPrebronchodilator FEV1Asthma exacerbationsAsthma symptomsExpiratory volumeCare utilizationClinical outcomesSecond percentageAsthma health statusAsthma severity classificationAsthma-related eventsChildhood Asthma Management ProgramEpisode-free daysNational Asthma EducationAsthma-related hospitalizationsPrevention Program guidelinesMean symptom scoreAsthma Management ProgramFuture adverse eventsOutcomes of interestMultivariate regression analysisPopulation of childrenClassification of severity
2002
Impact of Site of Care, Race, and Hispanic Ethnicity on Medication Use for Childhood Asthma
Ortega AN, Gergen PJ, Paltiel AD, Bauchner H, Belanger KD, Leaderer BP. Impact of Site of Care, Race, and Hispanic Ethnicity on Medication Use for Childhood Asthma. Pediatrics 2002, 109: e1-e1. PMID: 11773569, DOI: 10.1542/peds.109.1.e1.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Asthmatic AgentsAsthmaBlack or African AmericanChild, PreschoolConnecticutDrug UtilizationFemaleHealth Care SurveysHealth Services AccessibilityHispanic or LatinoHumansInsurance, Physician ServicesMaleMassachusettsMultivariate AnalysisPractice Patterns, Physicians'Private PracticeQuality of Health CareRetrospective StudiesSocioeconomic FactorsWhite PeopleConceptsSite of careHispanic ethnicityMedication useInsurance statusPatient raceSymptom severityAsthma medication useBeta2-agonist usePrimary care contactsHispanic childrenPrimary care visitsPrivate practiceParent-reported questionnaire dataSystemic steroidsCare contactsCare visitsUrgent visitsChildhood asthmaSteroid useRegular providerPatient levelNational guidelinesMultivariate analysisMaternal educationSignificant association